Skip to main content
Top
Published in: Journal of Translational Medicine 1/2019

Open Access 01-12-2019 | Melanoma | Research

E2F1 germline copy number variations and melanoma susceptibility

Authors: Maria Santa Rocca, Clara Benna, Simone Mocellin, Carlo Riccardo Rossi, Aichi Msaki, Andrea Di Nisio, Giuseppe Opocher, Carlo Foresta

Published in: Journal of Translational Medicine | Issue 1/2019

Login to get access

Abstract

Background

Melanoma is an aggressive type of skin cancer whose aetiology remains elusive as both environmental and genetic factors can contribute to its development. Recent studies have demonstrated the existence of multiple copies of E2F1 gene in melanoma specimens which could explain the deregulated E2F1 activity in this type of cancer. This finding suggests a key role for this transcription factor in the malignant transformation of melanocytes. Therefore, E2F1 has been considered as a potential therapeutic target for this form of skin cancer. Since germline copy number variations (CNVs) have been associated with increased susceptibility to different types of cancer, the aim of our study was to assess germline E2F1 CNV in melanoma patients. However, CNVs not necessarily lead to gene dosage imbalance, hence, further factors, in association with CNVs, could contribute to clinical manifestations. Considering that heat stress has been hypothesised as a contributing factor to skin cancer, we also investigated the effect of heat stress on E2F1 expression.

Methods

E2F1 CNV was measured in genomic DNA isolated from blood of 552 patients diagnosed with melanoma and 520 healthy subjects using TaqMan Copy Number Assays. E2F1 mRNA expression was also evaluated by RT-qPCR in the melanoma cell line, SK MEL 267, before and after exposure to heat stress.

Results

We found that patients diagnosed with melanoma (1.6%, 9/552) harboured frequently altered germline E2F1 copies compared to healthy subjects (0%, 0/520). Moreover, the difference among the two groups was statistically significant (p = 0.004). Furthermore, we found that heat exposure alone can significantly induce E2F1 expression.

Conclusions

This is the first study that shows a relation between germline E2F1 CNV and melanoma, suggesting that altered copies of this gene might be a predisposing factor to skin cancer. Our results also suggest that environmental insults, such as heat stress, could contribute to an aberrant E2F1 activity by inducing E2F1 mRNA expression. Therefore, subjects with multiple constitutive copies of E2F1 are at greater risk of developing melanoma when exposed to heat. Altogether our results corroborate with the hypothesis that susceptibility to melanoma depends on both the environment and genetic factors.
Literature
1.
go back to reference Pasquali S, Hadjinicolaou AV, ChiarionSileni V, Rossi CR, Mocellin S. Systemic treatments for metastatic cutaneous melanoma. Cochrane Database Syst Rev. 2018;2:CD011123.PubMed Pasquali S, Hadjinicolaou AV, ChiarionSileni V, Rossi CR, Mocellin S. Systemic treatments for metastatic cutaneous melanoma. Cochrane Database Syst Rev. 2018;2:CD011123.PubMed
2.
go back to reference Pfeifer GP, Besaratinia A. UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer. Photochem Photobiol Sci. 2012;11(1):90–7.CrossRef Pfeifer GP, Besaratinia A. UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer. Photochem Photobiol Sci. 2012;11(1):90–7.CrossRef
3.
go back to reference Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo. 2014;28(6):1005–11.PubMed Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo. 2014;28(6):1005–11.PubMed
4.
go back to reference Florell SR, Boucher KM, Garibotti G, Astle J, Kerber R, Mineau G, et al. Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol. 2005;23:7168–77.CrossRef Florell SR, Boucher KM, Garibotti G, Astle J, Kerber R, Mineau G, et al. Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol. 2005;23:7168–77.CrossRef
5.
go back to reference Valéry C, Grob JJ, Verrando P. Identification by cDNA microarray technology of genes modulated by artificial ultraviolet radiation in normal human melanocytes: relation to melanocarcinogenesis. J Invest Dermatol. 2001;117(6):1471–82.CrossRef Valéry C, Grob JJ, Verrando P. Identification by cDNA microarray technology of genes modulated by artificial ultraviolet radiation in normal human melanocytes: relation to melanocarcinogenesis. J Invest Dermatol. 2001;117(6):1471–82.CrossRef
6.
go back to reference Nelson MA, Radmacher MD, Simon R, Aickin M, Yang J, Panda L, et al. Chromosome abnormalities in malignant melanoma: clinical significance of nonrandom chromosome abnormalities in 206 cases. Cancer Genet Cytogenet. 2000;122(2):101–9.CrossRef Nelson MA, Radmacher MD, Simon R, Aickin M, Yang J, Panda L, et al. Chromosome abnormalities in malignant melanoma: clinical significance of nonrandom chromosome abnormalities in 206 cases. Cancer Genet Cytogenet. 2000;122(2):101–9.CrossRef
7.
go back to reference Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol. 2003;163(5):1765–70.CrossRef Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol. 2003;163(5):1765–70.CrossRef
8.
go back to reference Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353(20):2135–47.CrossRef Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353(20):2135–47.CrossRef
9.
go back to reference Sargent LM, Nelson MA, Lowry DT, Senft JR, Jefferson AM, Ariza ME, et al. Detection of three novel translocations and specific common chromosomal break sites in malignant melanoma by spectral karyotyping. Genes Chromosomes Cancer. 2001;32(1):18–25.CrossRef Sargent LM, Nelson MA, Lowry DT, Senft JR, Jefferson AM, Ariza ME, et al. Detection of three novel translocations and specific common chromosomal break sites in malignant melanoma by spectral karyotyping. Genes Chromosomes Cancer. 2001;32(1):18–25.CrossRef
10.
go back to reference Nelson MA, Reynolds SH, Rao UN, Goulet AC, Feng Y, Beas A, et al. Increased gene copy number of the transcription factor E2F1 in malignant melanoma. Cancer Biol Ther. 2006;5(4):407–12.CrossRef Nelson MA, Reynolds SH, Rao UN, Goulet AC, Feng Y, Beas A, et al. Increased gene copy number of the transcription factor E2F1 in malignant melanoma. Cancer Biol Ther. 2006;5(4):407–12.CrossRef
11.
go back to reference Johnson DG. The paradox of E2F1: oncogene and tumor suppressor gene. Mol Carcinog. 2000;27:151–7.CrossRef Johnson DG. The paradox of E2F1: oncogene and tumor suppressor gene. Mol Carcinog. 2000;27:151–7.CrossRef
12.
go back to reference Bertoli C, Klier S, McGowan C, Wittenberg C, de Bruin RA. Chk1 inhibits E2F6 repressor function in response to replication stress to maintain cell-cycle transcription. Curr Biol. 2013;23:1629–37.CrossRef Bertoli C, Klier S, McGowan C, Wittenberg C, de Bruin RA. Chk1 inhibits E2F6 repressor function in response to replication stress to maintain cell-cycle transcription. Curr Biol. 2013;23:1629–37.CrossRef
13.
go back to reference Shlien A, Malkin D. Copy number variations and cancer. Genome Med. 2009;1(6):62.CrossRef Shlien A, Malkin D. Copy number variations and cancer. Genome Med. 2009;1(6):62.CrossRef
14.
go back to reference Krepischi AC, Achatz MI, Santos EM, Costa SS, Lisboa BC, Brentani H, et al. Germline DNA copy number variation in familial and early-onset breast cancer. Breast Cancer Res. 2012;14(1):R24.CrossRef Krepischi AC, Achatz MI, Santos EM, Costa SS, Lisboa BC, Brentani H, et al. Germline DNA copy number variation in familial and early-onset breast cancer. Breast Cancer Res. 2012;14(1):R24.CrossRef
15.
go back to reference Huang KL, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, et al. Pathogenic germline variants in 10,389 adult cancers. Cell. 2018;173(2):355–70.CrossRef Huang KL, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, et al. Pathogenic germline variants in 10,389 adult cancers. Cell. 2018;173(2):355–70.CrossRef
16.
go back to reference Rocca MS, Di Nisio A, Marchiori A, Ghezzi M, Opocher G, Foresta C, et al. Copy number variations of E2F1: a new genetic risk factor for testicular cancer. Endocr Relat Cancer. 2017;24(3):119–25.CrossRef Rocca MS, Di Nisio A, Marchiori A, Ghezzi M, Opocher G, Foresta C, et al. Copy number variations of E2F1: a new genetic risk factor for testicular cancer. Endocr Relat Cancer. 2017;24(3):119–25.CrossRef
17.
go back to reference Calapre L, Gray ES, Ziman M. Heat stress: a risk factor for skin carcinogenesis. Cancer Lett. 2013;337(1):35–40.CrossRef Calapre L, Gray ES, Ziman M. Heat stress: a risk factor for skin carcinogenesis. Cancer Lett. 2013;337(1):35–40.CrossRef
18.
go back to reference Potrony M, Badenas C, Aguilera P, Puig-Butille JA, Carrera C, Malvehy J, et al. Update in genetic susceptibility in melanoma. Ann Transl Med. 2015;3(15):210.PubMedPubMedCentral Potrony M, Badenas C, Aguilera P, Puig-Butille JA, Carrera C, Malvehy J, et al. Update in genetic susceptibility in melanoma. Ann Transl Med. 2015;3(15):210.PubMedPubMedCentral
19.
go back to reference Hemminki K, Chen B. Familial risks in testicular cancer as aetiological clues. Int J Androl. 2006;29(1):205–10.CrossRef Hemminki K, Chen B. Familial risks in testicular cancer as aetiological clues. Int J Androl. 2006;29(1):205–10.CrossRef
20.
go back to reference Rouaud F, Hamouda-Tekaya N, Cerezo M, Abbe P, Zangari J, Hofman V, et al. E2F1 inhibition mediates cell death of metastatic melanoma. Cell Death Dis. 2018;9(5):527.CrossRef Rouaud F, Hamouda-Tekaya N, Cerezo M, Abbe P, Zangari J, Hofman V, et al. E2F1 inhibition mediates cell death of metastatic melanoma. Cell Death Dis. 2018;9(5):527.CrossRef
22.
go back to reference Maghsudlu M, Farashahi Yazd E. Heat-induced inflammation and its role in esophageal cancer. J Dig Dis. 2017;18(8):431–44.CrossRef Maghsudlu M, Farashahi Yazd E. Heat-induced inflammation and its role in esophageal cancer. J Dig Dis. 2017;18(8):431–44.CrossRef
Metadata
Title
E2F1 germline copy number variations and melanoma susceptibility
Authors
Maria Santa Rocca
Clara Benna
Simone Mocellin
Carlo Riccardo Rossi
Aichi Msaki
Andrea Di Nisio
Giuseppe Opocher
Carlo Foresta
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2019
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-019-1933-0

Other articles of this Issue 1/2019

Journal of Translational Medicine 1/2019 Go to the issue